Acquired a license for manufacturing medical device by MFDS: PNAClamp⑩ NRAS Detection Kit
CE marking [PANAMutyper⑩ R NRAS, KRAS]
Concluded partnership with Thermo Fisher Scientific for equipment supply[RT-PCR]
Concluded a supply contract of PANA RealTyper HPV with Italy distributo
   
CE marking [PANAMutyper⑩ R EGFR Detection Kit]
CE marking [PANA RealTyper⑩ HPV Detection Kit]
Acquired a license for manufacturing medical device by MFDS: PNAClamp⑩ KRAS(ver.2) Detection Kit
CE marking [PNAClamp⑩ KRAS(ver.4)]
   
Acquired a license for manufacturing medical device by MFDS: PNAClamp⑩ EGFR(ver.2) Detection Kit
Launched ‘PANAMutyper⑩ EGFR T790M, EGFR L858R, KRAS, NRAS (RUO)’(PANAMutyper⑩ R Series)
   
Awarded ‘Korea Technology Award (silver prize)’ and selected as ‘Korea Top 10 New Technologies 2013’
Acquired a license for manufacturing medical device by MFDS: PNAClamp⑩ IDH1 Detection Kit
Acquired a license for manufacturing medical device by Food and Drug Administration(KFDA):PANA qPCR⑩ TB/NTM Detection Kit
Acquired a license for manufacturing medical device by Food and Drug Administration (KFDA) : PNAClamp⑩ Mutation Detection Kit(EGFR, KRAS, BRAF)
   
Concluded supply & CFDA registration contract of PNAClamp⑩ Mutation Detection Kit with Beijing Siercheng Biotech. Co., Ltd.

Obtained ISO 13485:2003 certification [(PNAClamp⑩ Mutation Detection Kit, PANA qPCR⑩ TB/NTM Detection Kit)]

CE marking [(PNAClamp⑩ Mutation Detection Kit, PANA qPCR⑩ TB/NTM Detection Kit)]

Concluded supply & CFDA registration contract of PANArray⑩ HPV Genotyping Chip with Zhejiang Fuchon Medical Technology Co., ltd.

   

Concluded a supply contract of PNAClamp⑩ Mutation Detection Kit with Roche clinics

 

Concluded a co-partner agreement with Merck Serono

 

Concluded a supply contract with Abnova (supplies diagnostic products for research worldwide)

Transition into a sole representation by CEO, Kim Sung Kee

CE Marking (EGFR, KRAS, BRAF)

Received Technology Innovation Award from Frost & Sullivan, worldwide global market research and consulting institution

Developed PNAClamp⑩ Core Technology, Launched 3 products (EGFR/KRAS/BRAF)

 

CE marking (PANArray⑩ HPV Genotyping Chip:CE/1002)

 

Obtained ISO 13485:2003 certification(PANArray⑩ HPV Genotyping Chip)

 

Obtained ISO 9001:2008 certification (PNA and PANArray⑩ HPV Genotyping Chip)

Exclusive supply agreement of PANArray⑩ HPV Genotyping Chip with LG Life Sciences Ltd. in Korea

Acquisition of a non- exclusive licenese on microarray for human in vitro diagnostics in the world from Applied Biosystems, USA

   

Acquired a license for pharmaceutical manufacturing by Food and Drug Administration (KFDA) : PANArray⑩ HPV Genotyping Chip

 

Succeeded in the commercialization of world's first PNA Chip

Expansive rechartering of exclusive franchise agreement of PNA

Distributorship agreement with BioLinkk, Inida and Genoson, China

Changed the company name from Koram Panagene Ltd. to Panagene Inc.

   

M&A between Panagene Inc. and Koram Panagene Ltd. (listed in KOSDAQ)

Movement of headquarters to a new building at current address

Distributorship agreement with SBS Genetech, China

Distributorship agreement with Eurogentec, Belgium

   

Distributorship agreement with CPB, China

Acquired a non-exclusive license on PNA monomers

 

Concluded an exclusive supply contract with AdvanDx in U.S. (designed for diagnostic products in hospitals)

   

Distributorship agreement with CBC, Japan

Secured the core technology of PNA mass production and acquired of worldwide exclusive supply right

M&A with Koram Steel Ltd.

PNA supply agreement for commercial diagnostic kit with DAKO, Denmark

Concluded a PNA mass production contract with PPL in U.S.

   

Concluded a PNA supply contract with ISIS Pharmaceutical

Awarded at TIDES 2004 for best thesis

   

Nomination as a cluster R&D entrepreneur with the unique technology

Nomination as an Innovative Technology Company (INNO-BIZ) by KSMBA

   

"R&D Center of Chemical Biology" established

Patent filed on PNA Bts monomer and chemical process for unique synthesis of PNA oligomers

   

Foundation of Panagene Inc.